Jun Yoon insider trades
Open-market stock purchases and sales by Jun Yoon, CHIEF FINANCIAL OFFICER at Structure Therapeutics Inc, from SEC Form 4 filings since Feb 2, 2023.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +140%.
Companies traded
- GPCR Structure Therapeutics Inc: 1 buy, last Mar 19, 2026